Evidence map›Paper›PMID 36619006›Full record

ArticleCase reports in genetics2022

The Benefits of Early versus Late Therapeutic Intervention in Fabry Disease.

Mónica Furlano, Elisabet Ars, Anna Matamala, Vicens Brossa, Joan Martí, Maria Del Prado-Venegas, Jaume Crespi, Esther Roe, Roser Torra

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mónica FurlanoInherited Kidney Diseases, Nephrology Department, Fundació Puigvert, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Medicine Department-Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1025-3901
Elisabet ArsMolecular Biology Laboratory, Fundació Puigvert, Instituto de Investigaciones Biomédicas Sant Pau (IIB Sant Pau), Barcelona, Spain.ORCID https://orcid.org/0000-0002-4118-4358
Anna MatamalaInherited Kidney Diseases, Nursing Department, Fundació Puigvert, Barcelona, Spain.
Vicens BrossaCardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0003-0403-6425
Joan MartíDepartment of Neurology (Stroke Unit), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9229-8649
Maria Del Prado-VenegasDepartment of Otorhinolaryngology, Hospital de la Sta Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9048-4501
Jaume CrespiOphtalmology Department, Hospital de Sant Pau-Universitat Autonoma Barcelona, Barcelona, Spain.
Esther RoeDermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Roser TorraInherited Kidney Diseases, Nephrology Department, Fundació Puigvert, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Medicine Department-Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-8714-2332
Hospital de Sant Pau · ESUniversitat Autònoma de Barcelona · ESPuigvert Foundation · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by pathogenic variants of the Conclusions: These clinical cases suggest that initiating specific treatment at an earlier age in women with FD may prevent organ involvement and associated clinical events.

Identifiers

PMID36619006
PMCPMC9822754
OpenAlexW4313307556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.